Hypoxia-inducible factor-1 alpha (HIF-1a) is the regulatory subunit of the heterodimeric transcription factor HIF-1 and the key factor in cellular response to low oxygen tension. Expression of HIF-1a protein is associated with poor patient survival and therapy resistance in many types of solid tumors. Insight into HIF-1a regulation in solid tumors is important for therapeutic strategies. In this study, we determined the pathophysiological relevance of HIF-1a regulation by the oncogenic phosphatidylinositol 3 0 -kinase (PI 3-kinase)/Akt signaling pathway. We modeled the physiology of hypoxic tumor regions by culturing carcinoma cells under low oxygen tension in the absence of serum. We observed that hypoxic induction of HIF-1a protein was decreased by serum deprivation. Overexpression of dominant-active Akt1 restored HIF-1a expression, whereas inhibition of PI 3-kinase activity reduced hypoxic HIF-1a protein levels to a similar extent as serum deprivation. Immunohistochemical analysis of 95 human breast cancers revealed that lack of Akt1 phosphorylation correlates with low HIF-1a levels. To our knowledge, this is the first reported comparison between HIF-1a expression and Akt phosphorylation in human carcinomas. We conclude that Akt activity is physiologically relevant for HIF-1a expression in breast cancer. This implies that HIF-1a function might be therapeutically targeted by inhibition of the PI 3-kinase/ Akt pathway.
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The hypoxia-inducible factor-1 (HIF-1) is the main regulator of cellular adaptation to oxygen deprivation (Semenza, 2003 (Semenza, , 2004 . Hypoxia-inducible factor-1 is a heterodimeric transcription factor composed of a constitutively expressed subunit (HIF-1b or Ah receptor nuclear translocator), and a regulatory subunit (HIF1a), which is continuously degraded under normoxia (Wang et al., 1995; Jiang et al., 1996) . Expression of HIF-1a protein in solid tumors has been associated with tumor aggressiveness and poor clinical outcome (Birner et al., 2000; Bos et al., 2001; 2003; Dales et al., 2005; Vleugel et al., 2005) . Therefore, insight into HIF-1a regulation in solid tumors is important for therapeutic strategies. The mechanism of oxygen-dependent regulation of HIF-1a has been studied extensively. Under normoxia, HIF-1a is hydroxylated by specific prolyl hydroxylases, which allows binding of the E3 ubiquitin ligase Von Hippel-Lindau protein (pVHL) and subsequent HIF-1a degradation by the proteasome (Maxwell et al., 1999; Bruick and McKnight, 2001; Epstein et al., 2001; Ivan et al., 2001; Jaakkola et al., 2001) . When oxygen tension is severely reduced, HIF-1a is no longer hydroxylated and becomes stabilized. Stabilization of HIF-1a results in the transcription of HIF-1 target genes, such as vascular endothelial growth factor (VEGF) (Levy et al., 1995; Forsythe et al., 1996; Semenza, 2003) . In addition to VHL-dependent regulation, oncogenic signaling pathways regulate HIF-1a. For instance, the PI 3-kinase/Akt or protein kinase B (PKB) signal-transduction cascade has been implicated in the regulation of HIF-1a either under hypoxic conditions or in response to stimulation of tyrosine kinase receptors (Jiang et al., 2001; Fukuda et al., 2002) . The exact contribution of the PI 3-kinase pathway to HIF-1a regulation is still subject of discussion (AlvarezTejado et al., 2002; Arsham et al., 2002) .
The aim of our study was to gain insight into the pathophysiological relevance of HIF-1a regulation by the PI 3-kinase/Akt pathway. To do so, we considered a model to study HIF-1a regulation in the hypoxic regions of a tumor. Lack of oxygen supply from the blood vessels coincides with decreased availability of nutrients and growth factors. This unfavorable environment results in a strong selective pressure for the most adaptive and malignant tumor cells (Vaupel and Mayer, 2005) . Culturing cells under hypoxia and low serum conditions reflects the physiology of these hypoxic tumor regions. To study HIF-1a in this model, cervical carcinoma-derived HeLa cells and breast carcinomaderived MCF-7 cells were cultured in the presence or absence of fetal calf serum (FCS) for 24 h followed by incubation in a hypoxic environment (1% O 2 ) for 4 h. In the presence of serum, HIF-1a protein levels were induced by hypoxia in both cell lines (Figure 1a) . However, in serum-deprived HeLa and MCF-7 cells, only little HIF-1a protein was detectable after incubation under hypoxic conditions. To study presumable influences of FCS on the activity of the PI 3-kinase pathway, phosphorylation of Akt1 on serine 473 was determined (Alessi et al., 1996) . In serum-deprived HeLa and MCF-7 cells, Akt1 phosphorylation was decreased compared to serum-maintained cells, whereas total Akt1 levels remained unchanged. Interestingly, the effect of serum deprivation on levels of HIF-1a induction coincides with the effect on Akt1 phosphorylation.
Vascular endothelial growth factor transcription is induced under hypoxia in an HIF-1-dependent manner (Levy et al., 1995) . We studied VEGF regulation under hypoxia to determine whether or not the inhibition of HIF-1a protein induction by serum deprivation resulted in reduced HIF-1 transcriptional activity. HeLa cells were transiently transfected with a luciferase reporter construct under the control of five hypoxia-responsive elements (HRE) derived from the VEGF promotor (Shibata et al., 1998) . Transcriptional activity of HIF-1 was detected when cells were cultured under hypoxic conditions in the presence of serum (Figure 1b ). In the absence of serum, activation by hypoxia was distinguishably attenuated. In addition, VEGF mRNA expression in HeLa cells was analysed by quantitative polymerase chain reaction (PCR) to confirm effects of serum deprivation on endogenous gene regulation by HIF-1a. Expression of VEGF mRNA was induced in HeLa cells after incubation in a hypoxic environment in the presence of serum (Figure 1c ). In the absence of serum, VEGF mRNA expression was significantly less induced. In conclusion, these data show that serum deprivation impairs induction of HIF-1a protein and subsequent gene regulation by HIF-1 in response to hypoxia, which corresponds with a decrease in Akt1 phosphorylation.
To test whether the observed reduction in hypoxiainduced HIF-1a protein expression in HeLa after serum deprivation was caused by the reduced PI 3-kinase activity, serum-deprived HeLa cells were transfected with constitutively active Akt1 (Burgering and Coffer, 1995) . This resulted in substantial induction of HIF-1a protein levels by hypoxia (Figure 2a) . Overexpression of constitutively active Akt1 did not enhance hypoxic HIF1a expression in the presence of serum, which suggests that the effects of serum maintenance and Akt1 overexpression are not additive. Under normoxic condition, HIF-1a protein expression was not induced by constitutively active Akt1, whereas overexpressed HIF-1a could be detected, showing that Akt1 activity alone is not sufficient for HIF-1a induction (Figure 2b ). To study whether the PI 3-kinase/Akt pathway is necessary for HIF-1a protein expression, HeLa cells were cultured in the presence or absence of serum and treated with the PI 3-kinase inhibitor LY294002. Inhibition of PI 3-kinase resulted in reduction of hypoxia-induced HIF-1a Figure 1 Induction of hypoxia-inducible factor-1a (HIF-1a) protein and function by hypoxia is impaired after serum deprivation. (a) Western analysis of serum-and oxygen-deprived cells. Cells were cultured in Dulbecco's modified Eagle's medium (Gibco BRL, UK) supplied with 10% fetal calf serum (FCS) (Gibco BRL, UK). Cells were serum-maintained or -deprived for 24 h and incubated for 4 h under hypoxia (1% O 2 ) in an invivo 2 1000 Workstation (Biotrace, UK). Cells were lysed in Laemmli sample buffer (Laemmli, 1970) . Twenty microgram protein/lane was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by Western blot analysis. Blots were incubated overnight with anti-HIF1a (1:250; BD Transduction Laboratories, CA, USA), anti-Akt (phospho-S473) (1:1000; Abcam, UK), anti-Akt (1:1000; Abcam, UK) or anti-b-actin (1:5000; US Biological, Swampscott, MA, USA) at 41C. Enhanced Chemo Luminescence (ECL, Amersham Biosciences, UK) was used for signal detection according to the manufacturers' protocol. (b) Hypoxia-inducible factor-1 reporter analysis in serumand oxygen-deprived cells. HeLa cells were co-transfected with TK Renilla (Promega Corporation, WI, USA) and either empty pGL3 (Promega Corporation, WI, USA) or pGL3 vector containing five hypoxia-responsive elements (5 Â HRE) (Shibata et al., 1998) 24 h before treatment using Lipofectamin 2000 & (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Cells were serum-maintained or -deprived for 24 h and subsequently incubated under hypoxia (1% O 2 ) for 16 h or left untreated. Cells were lysed in 1 Â Passive lysis buffer (Promega Corporation, Madison, WI, USA) according to manufacturer's protocol. Experiments were performed in triplicate. Samples were assayed with a dual luciferase kit (Promega Corporation, Madison, WI, USA) and measured using a Veritas TM 96-well plate luminometer (Turner Biosystems, Sunnyvale, CA, USA). All values were normalized using TK Renilla expression. Data represent the 5 Â HRE value divided by pGL3 value. (c) Quantitative vascular endothelial growth factor (VEGF) mRNA analysis in serumand oxygen-deprived cells. HeLa cells were serum-maintained ordeprived for 24 h and subsequently incubated under hypoxia (1% O 2 ) for 24 h or left untreated. Total RNA was isolated from cell lysates using Trizol followed by chloroform/phenol extraction. cDNA was made using a Reverse Transcriptase kit (Roche, Germany) and oligo-(dT) primers (Invitrogen, CA, USA). Quantitative PCR was performed with AssayOnDemand kits for VEGF and hydroxymethylbilane synthase (HMBS) (Applied Biosystems, CA, USA) using an ABI7900 analyzer (Applied Biosystems, CA, USA). Data were analyzed using the SDS2.2.1 program (Applied Biosystems, CA, USA). Vascular endothelial growth factor expression was normalized using expression levels of HMBS. cDNA from HeLa cells incubated with serum under normoxia served as a reference.
HiF-1a requires PI 3-kinase EH Gort et al protein levels to a similar extent as serum deprivation (Figure 2c ). Expression of HIF-1a protein was not completely abolished. This might be explained by basal translation of HIF-1a, which is enhanced by PI 3-kinase activity (Hudson et al., 2002) . The mammalian target of rapamycin (mTOR) is an effector in the PI-3-kinase pathway involved in translational regulation by phosphorylating 4EBP and p70S6K (Hay and Sonenberg, 2004) . To address whether the specific mTOR inhibitor rapamycin had an effect on HIF-1a levels, HeLa cells were cultured in the absence or presence of serum and treated with rapamycin. Hypoxic induction of HIF-1a was reduced by rapamycin in the presence of serum (Figure 2d ). Further, serum deprivation only resulted in minor additional impairment of HIF-1a induction. These data indicate that lack of PI 3-kinase or mTOR activity severely limits HIF-1a protein expression. Based on these results in our in vitro model, one would expect that HIF-1a expression in solid tumors largely depends on Akt activity. Akt1 phosphorylation on serine 473 has been suggested to be associated with aggressiveness in carcinomas (Kreisberg et al., 2004; Schmitz et al., 2004; Kirkegaard et al., 2005) . However, no association studies with HIF-1a have been reported yet. We therefore examined the expression and correlation of HIF-1a protein and phosphorylated Akt1 in 129 cases of invasive breast cancer. Hematoxylin-eosinstained sections were used to identify representative areas of tumor tissue in tissue blocks, from which a tissue microarray was constructed. The average age of the patients was 65.5 years, 40% were lymph-node positive and the average tumor size was 2.26 cm 2 . The tissue microarray was analysed by immunohistochemistry for HIF-1a protein and for phosphorylated Akt1. Staining could be analysed for both proteins in 95 cases. Phosphorylated Akt1 was observed in the majority of the breast carcinomas, but not in normal breast tissue. An Akt1 score was assigned to each case based on product of the percentage of positive tumor nuclei and semiquantitatively assessed staining intensity (0-3), taking the mean Akt1 score as cutoff to discriminate between high and low Akt1 phosphorylation. Low Akt1 phosphorylation was observed in 38 patients. From these patients, only six patients (16%) had HIF-1a expression in more than 5% of the tumor cells and none had HIF-1a expression in more than 50% of the tumor cells (Figure 3 ). In patients with high-Akt1 phosphorylation, the HIF-1a expression levels were not necessarily high or low. Therefore, we conclude that a low expression of phosphorylated Akt1 correlates with low (Burgering & Coffer, 1995) or with pCEP4-HIF-1a , or an empty pcDNA3 vector (Invitrogen, CA, USA) 24 h before treatment using Lipofectamin 2000 & according to the manufacturer's protocol. When indicated, cells were serum-maintained or -deprived for 24 h before incubation for 4 h under hypoxia (1% O 2 ). Western blot analysis was performed as described in Figure 1a legend. (c) Western analysis of hypoxic HeLa cells treated with a PI 3-kinase inhibitor. HeLa cells were treated with 10 mM of the PI 3-kinase inhibitor LY294002 (Sigma-Aldrich Co., St Louis, MO, USA) for 30 min before incubation for 4 h under hypoxia (1% O 2 ). When indicated, cells were serum-maintained or -deprived for 24 h before hypoxia. Western blot analysis was performed as described in Figure 1a legend. (d) Western analysis of hypoxic HeLa cells treated with rapamycin. HeLa cells were treated with 12.5 mM of the mammalian target of rapamycin (mTOR) inhibitor rapamycin (Sigma-Aldrich Co., St Louis, MO, USA) 24 h before incubation for 4 h under hypoxia (1% O 2 ). When indicated, cells were serum-maintained or -deprived for 24 h before hypoxia. Western blot analysis was performed as described in Figure 1a legend.
HiF-1a requires PI 3-kinase EH Gort et al expression of HIF-1a in breast cancer (P ¼ 0.026 for HIF-1a expression less then 5%). This is in agreement with our observations that reduced PI 3-kinase/Akt activity in serum-deprived cells limits HIF-1a expression and that a high level of active Akt alone is not sufficient for HIF-1a accumulation. Most likely, HIF-1a protein expression requires both inhibition of pVHL-dependent HIF-1a degradation by hypoxia and Akt-induced HIF1a translation. Therefore, lack of hypoxia in some of the tumor samples is a plausible explanation for this observation. Furthermore, we cannot exclude the involvement of other signaling pathways.
Even though oxygen-dependent hydroxylation of HIF-1a remains the main regulatory mechanism, the PI 3-kinase/Akt pathway takes an important place in HIF-1 regulation. It remains to be determined which effectors of the PI 3-kinase/Akt pathway are responsible for the observations made in this study. Many downstream targets of Akt have been implicated in regulating HIF-1a protein expression and function, like TSC-2, mTOR, GSK-3b, FOXO4, HDM2 and heat-shock proteins (Zhong et al., 2000; Hudson et al., 2002; Treins et al., 2002; Brugarolas et al., 2003; Mottet et al., 2003; Tang and Lasky, 2003; Bardos et al., 2004; Skinner et al., 2004; Zhou et al., 2004) . Some of these Akt effectors have been indicated to regulate translation of HIF-1a, whereas others might regulate HIF-1a degradation (Hudson et al., 2002; Brugarolas et al., 2003; Zhou et al., 2004) . The effects of serum deprivation on HIF-1a could still be observed after inhibition of degradation of HIF-1a (data not shown). Furthermore, treatment with rapamycin reduced hypoxia-induced HIF-1a expression. This might implicate that Akt mainly influences HIF-1a synthesis, partially via an mTOR-dependent mechanism.
In breast cancer, Akt activity predicts clinical outcome (Schmitz et al., 2004; Kirkegaard et al., 2005) . We are the first to report a link between Akt phosphorylation status and HIF-1a expression in invasive breast carcinomas. Our data show that active Akt is necessary for high HIF-1a expression. Therefore, it might be possible to target HIF-1a-mediated tumor aggressiveness through inhibition of Akt activity. Clinical trials using Akt or PI 3-kinase inhibitors might give more insight into the mechanism by which Akt-dependent regulation of HIF-1a affects tumor aggressiveness of hypoxic tumors and patient survival. Figure 3 Hypoxia-inducible factor-1a (HIF-1a) protein expression correlates with Akt1 phosphorylation. Tumor A represents breast carcinoma tissue with a high HIF-1a expression and a high Akt1 phosphorylation score. Tumor B represents breast carcinoma tissue with low HIF-1a expression and a low Akt1 phosphorylation score. The tissue array was constructed by taking 4-5 mm cores from neutral-buffered formaldehyde-fixed paraffin blocks of breast cancer tissues obtained from the archives of the Department of Pathology of the VU University Medical Center, Amsterdam, using a dedicated instrument (Beecher, Sun Prairie, WI, USA). The use of anonymous or coded left over material for scientific purposes is part of the standard treatment contract with patients (van Diest, 2002) . Immunohistochemistry for HIF-1a was performed as described previously (Bos et al., 2003) . Antigen retrieval for phosphorylated Akt1 was carried out by boiling sections in citratebuffered solution for 15 min. Staining was performed with anti-Akt (phospho-S473) (1:100; Abcam, UK) followed by incubation with PowerVision Poly-Hrp-anti Ms/Rb/Rt IgG (Biotin-free, Ready to use; Immuno Vision Technologies, Dalycity, CA, USA). Data were analysed using SPSS for Windows, version 12.0.1 (SPSS Inc., Chicago, IL, USA). The non-parametric w 2 test was used to evaluate correlations between HIF-1a expression and Akt1 phosphorylation. Two-sided P-values o0.05 were considered significant.
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